SAREPTA THERAPEUTICS

Live / Registered — Registered and renewed (as of 01 May 2025)

What this means for you

Registered since 09 Dec 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Dec 2024).

Record

Serial number
85643841
Registration number
4653265
Mark type
Stylized text
Filed
05 Jun 2012
Published for opposition
05 Mar 2013
Registered
09 Dec 2014
Next maintenance due
09 Dec 2024
Attorney of record
Paul C. Llewellyn

Goods and services

  • Class 005 — Pharmaceuticals: pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies )) ; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression
  • Class 042 — Scientific and technological services: medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies

Owner

Prosecution history

  • 01 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
  • 01 May 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
  • 01 May 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
  • 01 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 04 Dec 2024 — TEAS SECTION 8 & 9 RECEIVED
  • 09 Dec 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
  • 01 Jun 2021 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
  • 01 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 01 Jun 2021 — REGISTERED - SEC. 15 ACKNOWLEDGED
  • 01 Jun 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
  • 01 Jun 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 16 Nov 2020 — TEAS SECTION 15 RECEIVED
  • 16 Nov 2020 — TEAS SECTION 8 RECEIVED
  • 09 Dec 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 02 Mar 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED

View this trademark record on Marksy